<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35436559</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1874-1754</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>358</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of cardiology</Title>
          <ISOAbbreviation>Int J Cardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach.</ArticleTitle>
        <Pagination>
          <StartPage>136</StartPage>
          <EndPage>139</EndPage>
          <MedlinePgn>136-139</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2022.04.024</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0167-5273(22)00504-6</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Complications following COVID-19 vaccination, particularly with mRNA vaccines, rarely include myocarditis and pericarditis. This work principally aimed at defining a realistic temporal relationship between vaccination and myocarditis/pericarditis development.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">All relevant cases reported from week 52/2020 through week 41/2021 in the VAERS database were retrieved and analyzed for licensed vaccines. These included BNT162b2, mRNA-1273, and AD26.COV2·S. Incidence rates were calculated using the corresponding administered vaccine doses as denominators. Additionally, analyzed parameters included demographics, dose series, hospitalization length and outcome.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 2016 myocarditis and 1380 pericarditis cases, (4.96/10<sup>6</sup> and 3.40/10<sup>6</sup> administered vaccine doses, respectively), were recorded. Most myocarditis cases occurred following BNT162b2 (5.60/10<sup>6</sup> doses) in males &lt;30 years. Pericarditis affected predominantly males &lt;40, both sexes &gt;40 years, and was most common post AD26.COV2·S (4.78/10<sup>6</sup> doses). Hospitalization was required for 40.3% and 27.2% of myocarditis and pericarditis cases, respectively. A bimodal pattern was found for both myocarditis and pericarditis, with two peaks that coincided temporally, but were reversed in intensity. The first peak was recorded 1-3 days post-vaccination and was more pronounced in myocarditis, while the second was recorded 15-30 days post-vaccination and was more intense in pericarditis.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Myocarditis/pericarditis after COVID-19 vaccination is rare and depicts a bimodal pattern.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Anastassopoulou</LastName>
            <ForeName>Cleo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hatziantoniou</LastName>
            <ForeName>Sophia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vlachopoulos</LastName>
            <ForeName>Charalambos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spanakis</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsioufis</LastName>
            <ForeName>Costas</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsakris</LastName>
            <ForeName>Athanasios</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lazaros</LastName>
            <ForeName>George</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: glaz35@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Cardiol</MedlineTA>
        <NlmUniqueID>8200291</NlmUniqueID>
        <ISSNLinking>0167-5273</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000090984">Ad26COVS1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N38TVC63NU</RegistryNumber>
          <NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000090984" MajorTopicYN="N">Ad26COVS1</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010493" MajorTopicYN="Y">Pericarditis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword>
        <Keyword MajorTopicYN="N">Myocarditis</Keyword>
        <Keyword MajorTopicYN="N">Onset interval</Keyword>
        <Keyword MajorTopicYN="N">Pericarditis</Keyword>
        <Keyword MajorTopicYN="N">VAERS</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>20</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35436559</ArticleId>
        <ArticleId IdType="pmc">PMC9011898</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ijcard.2022.04.024</ArticleId>
        <ArticleId IdType="pii">S0167-5273(22)00504-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hendren N.S., Carter S., Grodin J.L. Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn? Int. J. Cardiol. 2021;343:197–198. doi: 10.1016/j.ijcard.2021.09.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2021.09.036</ArticleId>
            <ArticleId IdType="pmc">PMC8453875</ArticleId>
            <ArticleId IdType="pubmed">34560165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbate A., Gavin J., Madanchi N., et al.  Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int. J. Cardiol. 2021;340:119–121. doi: 10.1016/j.ijcard.2021.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2021.08.018</ArticleId>
            <ArticleId IdType="pmc">PMC8372420</ArticleId>
            <ArticleId IdType="pubmed">34416319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazaros G., Klein A.L., Hatziantoniou S., et al.  The novel platform of mRNA COVID-19 vaccines and myocarditis: clues into the potential underlying mechanism. Vaccine. 2021;39:4925–4927. doi: 10.1016/j.vaccine.2021.07.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2021.07.016</ArticleId>
            <ArticleId IdType="pmc">PMC8275472</ArticleId>
            <ArticleId IdType="pubmed">34312010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazaros G., Anastassopoulou C., Hatziantoniou S., et al.  A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine. 2021;39:6585–6590. doi: 10.1016/j.vaccine.2021.09.078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2021.09.078</ArticleId>
            <ArticleId IdType="pmc">PMC8491922</ArticleId>
            <ArticleId IdType="pubmed">34635376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaccine Adverse Event Reporting System. 2021. https://vaers.hhs.gov/ (accessed on October 28.</Citation>
        </Reference>
        <Reference>
          <Citation>Kreimeyer K., Menschik D., Winiecki S., et al.  Probabilistic record linkage of structured and unstructured data to identify duplicate cases in spontaneous adverse event reporting systems. Drug Saf. 2017;40:571–582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28293864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritchie H., Ortiz-Ospina E., Beltekian D., et al.  Coronavirus Pandemic (COVID-19) 2020. https://ourworldindata.org/coronavirus [accessed on October 15, 2021]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7545176</ArticleId>
            <ArticleId IdType="pubmed">33033256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diaz G.A., Parsons G.T., Gering S.K., et al.  Myocarditis and pericarditis After vaccination for COVID-19. JAMA. 2021;326:1210–1212. doi: 10.1001/jama.2021.13443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2021.13443</ArticleId>
            <ArticleId IdType="pmc">PMC8340007</ArticleId>
            <ArticleId IdType="pubmed">34347001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patone M., Mei X.W., Handunnetthi L., et al.  Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2021 doi: 10.1038/s41591-021-01630-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId>
            <ArticleId IdType="pmc">PMC8863574</ArticleId>
            <ArticleId IdType="pubmed">34907393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oster M.E., Shay D.K., Su J.R., et al.  Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327:331–340. doi: 10.1001/jama.2021.24110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2021.24110</ArticleId>
            <ArticleId IdType="pmc">PMC8790664</ArticleId>
            <ArticleId IdType="pubmed">35076665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montgomery J., Ryan M., Engler R., et al.  Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6:1202–1206. doi: 10.1001/jamacardio.2021.2833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId>
            <ArticleId IdType="pmc">PMC8243257</ArticleId>
            <ArticleId IdType="pubmed">34185045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez Y., Levy E.R., Joshi A.Y., et al.  Myocarditis following COVID-19 mRNA vaccine: a case series and incidence rate determination. Clin. Infect. Dis. 2021:ciab926. doi: 10.1093/cid/ciab926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciab926</ArticleId>
            <ArticleId IdType="pmc">PMC8767838</ArticleId>
            <ArticleId IdType="pubmed">34734240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein N.P., Lewis N., Goddard K., et al.  Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021;326:1390–1399. doi: 10.1001/jama.2021.15072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2021.15072</ArticleId>
            <ArticleId IdType="pmc">PMC8511971</ArticleId>
            <ArticleId IdType="pubmed">34477808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frangogiannis N.G. The significance of COVID-19-associated myocardial injury: how overinterpretation of scientific findings can fuel media sensationalism and spread misinformation. Eur. Heart J. 2020;41:3836–3838. doi: 10.1093/eurheartj/ehaa727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehaa727</ArticleId>
            <ArticleId IdType="pmc">PMC7599034</ArticleId>
            <ArticleId IdType="pubmed">33006608</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
